Opioid use disorder during pregnancy in Tennessee: Expediency vs. science

American Journal of Drug and Alcohol Abuse

Volumn 41, Issue 5, 2015, Pages 367-370

  Martin, Peter R ^a   Finlayson, A J Reid ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Buprenorphine; Methadone; Opioid use disorder; Policy; Pregnancy

Indexed keywords

BUPRENORPHINE; METHADONE; OPIATE;

CLINICAL PRACTICE; FEMALE; HUMAN; INJECTION; MAINTENANCE THERAPY; MEDICAID; METHADONE TREATMENT; OPIATE ADDICTION; PREGNANCY; PREGNANCY DISORDER; PREGNANT WOMAN; PRESCRIPTION; REIMBURSEMENT; REVIEW; UNITED STATES; URBAN POPULATION; ECONOMICS; INSURANCE; LEGISLATION AND JURISPRUDENCE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; POLITICS; PREGNANCY COMPLICATIONS; TENNESSEE; UTILIZATION;

BUPRENORPHINE; FEMALE; HUMANS; INSURANCE COVERAGE; MEDICAID; METHADONE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; POLITICS; PREGNANCY; PREGNANCY COMPLICATIONS; TENNESSEE; UNITED STATES;

EID: 84941092562     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2015.1047502     Document Type: Review

References (24)

1. Young JL, Martin PR. Treatment of opioid dependence in the setting of pregnancy. Psychiatric Clin North Am 2012; 35: 441-460.
2. Bier JB, Finger AS, Bier BA, Johnson TA, Coyle MG. Growth and developmental outcome of infants with in-utero exposure to methadone vs buprenorphine. J Perinatol 2015; 4: 2. Epub 2015 Apr 2.
3. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA 2012; 307: 1934-1940.
4. Warren M, Miller A, Traylor J, Bauer A, Patrick S. Implementation of a statewide surveillance system for Neonatal Abstinence Syndrome-Tennessee, 2013. MMWR 2015; 64: 125-128.
5. Epstein RA, Bobo WV, Martin PR, Morrow JA, Wang W, Chandrasekhar R, Cooper WO. Increasing pregnancy-related use of prescribed opioid analgesics. Ann Epidemiol 2013; 23: 498-503.
6. Patrick SW, Dudley J, Martin PR, Harrell FE, Warren MD, Hartmann KE, Ely EW, et al. Prescription opioid epidemic and infant outcomes: analysis of over 100,000 pregnancies. Pediatrics 2015; 135: 842-850.
7. Paulozzi L, Mack K, Hockenberry J. Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines-United States, 2012. MMWR 2014; 63: 563-568.
8. Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy: effects and management. Obset Gynecol Clin North Am 1998; 25: 139-151.
9. Substance Abuse and Mental Health Services Administration (SAMHSA). Medicaid coverage and financing of medications to treat alcohol and opioid use disorders. HHS Publication No. SMA-14-4854. Rockville, MD: SAMHSA; 2014.
10. Haegerich TM, Paulozzi LJ, Manns BJ, Jones CM. What we know, and dont know, about the impact of state policy and systems-level interventions on prescription drug overdose. Drug Alcohol Depend 2014; 145: 34-47.
11. Winklbaur B, Kopf N, Ebner N, Jung E, Thau K, Fischer G. Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Addiction 2008; 103: 1429-1440.
12. Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, OGrady KE, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. New Eng J Med 2010; 363: 2320-2331.
13. Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, Green JL. Trends in opioid analgesic abuse and mortality in the United States. New Engl J Med 2015; 372: 241-248.
14. Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers-United States, 2002-2004 and 2008-2010. Drug Alcohol Depend 2013; 132: 95-100.
15. Substance Abuse and Mental Health Services Administration (SAMSHA). Results from the 2010 national survey on drug use and health: summary of national findings. [NSDUH Series H-41, HHS Publication No. (SMA) 11-4658]. Rockville, MD: SAMHSA; 2011.
16. McGowan CC, Weinstein DD, Samenow CP, Stinnette SE, Barkanic G, Rebeiro PF, Sterling TR, et al. Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two US clinic cohorts. PLoS One 2011; 6: e18462.
17. Centers for Disease Control and Prevention (CDC). CDC grand rounds: prescription drug overdoses-a U.S. epidemic. MMWR 2012; 61: 10-13.
18. Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, Alexander GC. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Ann Rev Public Health 2015; 36: 359-574.
19. Brogly SB, Saia KA, Walley AY, Du HM, Sebastiani P. Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis. Am J Epidemiol 2014; 180: 673-686.
20. Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2014; CD002207.
21. Meyer MC, Johnston AM, Crocker AM, Heil SH. Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study. J Addiction Med 2015; 9: 81-86.
22. Stöver H, Schäffer D. SMOKE IT! Promoting a change of opiate consumption pattern-from injecting to inhaling. Harm Reduct J 2014: 11: 18.
23. Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, Gardin J, et al. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry 2011; 68: 1238-1246.
24. Jones HE, Heil SH, Baewert A, Arria AM, Kaltenbach K, Martin PR, Coyle MG, et al. Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction 2012; 107: 5-27